Eli Lilly's Obesity Drug Amylin Shows Up to 20% Weight Loss in Study
The Eli Lilly Biotechnology Center is shown in San Diego, California, on March 1, 2023. Mike Blake | Reuters Eli…
The Eli Lilly Biotechnology Center is shown in San Diego, California, on March 1, 2023. Mike Blake | Reuters Eli…
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Albert Bourla, CEO of Pfizer, speaks during a press conference after a visit to oversee the production of the Pfizer-BioNtech…
A Pfizer logo is displayed at a research center in the La Jolla neighborhood of San Diego, California, U.S., on…
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Eli Lilly shares rose Thursday after the drugmaker posted a strong third quarter, boosted by sales of its popular GLP-1…
David Ricks, CEO of Eli Lilly & Co., during a press conference at Generation Park in Houston, Texas, U.S., Tuesday,…
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
The logos of Danish pharmaceutical company Novo Nordisk, maker of the successful diabetes and weight loss treatments Ozempic and Wegovy,…
Novo Nordisk flags fly in front of its office in Bagsvaerd, outside Copenhagen, Denmark, on July 14, 2025. Little Tom…